Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma

Weil, 2005, Breast cancer metastasis to the central nervous system, Am. J. Pathol., 167, 913, 10.1016/S0002-9440(10)61180-7 Johnson, 2012, Glioblastoma survival in the United States before and during the temozolomide era, J. Neuro-Oncol., 107, 359, 10.1007/s11060-011-0749-4 Donahue, 2008, Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches, Magn. Reson. Med., 59, 336, 10.1002/mrm.21467 Lichter, 1995, Recent advances in radiation oncology, N. Engl. J. Med., 332, 371, 10.1056/NEJM199502093320607 Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2, 751, 10.1038/nnano.2007.387 Agarwal, 2011, Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain, Expert Rev. Mol. Med., 13, 10.1017/S1462399411001888 Lakkadwala, 2018, Dual functionalized 5-fluorouracil liposomes as highly efficient nanomedicine for glioblastoma treatment as assessed in an in vitro brain tumor model, J. Pharm. Sci., 107, 2902, 10.1016/j.xphs.2018.07.020 Lakkadwala, 2019, Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model, Colloids Surf. B: Biointerfaces, 173, 27, 10.1016/j.colsurfb.2018.09.047 Qian, 2002, Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway, Pharmacol. Rev., 54, 561, 10.1124/pr.54.4.561 Sharma, 2012, Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood-brain barrier model, J. Pharm. Sci., 101, 2468, 10.1002/jps.23152 Prabhakar, 2011, Brain delivery of transferrin coupled indinavir submicron lipid emulsions-pharmacokinetics and tissue distribution, Colloids Surf. B: Biointerfaces, 86, 305, 10.1016/j.colsurfb.2011.04.013 Skarlatos, 1995, Transport of [125I]transferrin through the rat blood-brain barrier, Brain Res., 683, 164, 10.1016/0006-8993(95)00363-U Kibria, 2011, Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery, J. Control. Release, 153, 141, 10.1016/j.jconrel.2011.03.012 Zong, 2014, Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals, Mol. Pharm., 11, 2346, 10.1021/mp500057n Bolhassani, 2011, Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer, Biochim. Biophys. Acta Rev. Cancer, 1816, 232, 10.1016/j.bbcan.2011.07.006 Sharma, 2016, The role of cell-penetrating peptide and transferrin on enhanced delivery of drug to brain, Int. J. Mol. Sci., 17, 806, 10.3390/ijms17060806 Derossi, 1994, The third helix of the Antennapedia homeodomain translocates through biological membranes, J. Biol. Chem., 269, 10444, 10.1016/S0021-9258(17)34080-2 Odabaei, 2004, Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis, Adv. Cancer Res., 91, 169, 10.1016/S0065-230X(04)91005-6 Stuhlmiller, 2015, Inhibition of lapatinib-induced kinome reprogramming in ERBB2-positive breast cancer by targeting BET family bromodomains, Cell Rep., 11, 390, 10.1016/j.celrep.2015.03.037 Li, 2009, Targeted delivery of doxorubicin using stealth liposomes modified with transferrin, Int. J. Pharm., 373, 116, 10.1016/j.ijpharm.2009.01.023 Sharma, 2014, Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier, Pharm. Res., 31, 1194, 10.1007/s11095-013-1242-x Ying, 2010, Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals, J. Control. Release, 141, 183, 10.1016/j.jconrel.2009.09.020 Wang, 2013, Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis, PLoS One, 8 Nag, 2013, Surface engineering of liposomes for stealth behavior, Pharmaceutics, 5, 542, 10.3390/pharmaceutics5040542 Iden, 2001, In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach, Biochim. Biophys. Acta, 1513, 207, 10.1016/S0005-2736(01)00357-1 Moreira, 2002, Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity, Pharm. Res., 19, 265, 10.1023/A:1014434732752 Torchilin, 1979, Preservation of antimyosin antibody activity after covalent coupling to liposomes, Biochem. Biophys. Res. Commun., 89, 1114, 10.1016/0006-291X(79)92123-5 Marqués-Gallego, 2014, Ligation strategies for targeting liposomal nanocarriers, Biomed. Res. Int., 2014, 10.1155/2014/129458 Barenholz, 2012, Doxil® — the first FDA-approved nano-drug: lessons learned, J. Control. Release, 160, 117, 10.1016/j.jconrel.2012.03.020 Chen, 2012, Modern methods for delivery of drugs across the blood-brain barrier, Adv. Drug Deliv. Rev., 64, 640, 10.1016/j.addr.2011.11.010 Zhao, 2012, The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel, Biomaterials, 33, 2508, 10.1016/j.biomaterials.2011.11.078 Wang, 2012, The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer, Biomaterials, 33, 8451, 10.1016/j.biomaterials.2012.08.031 Trabulo, 2010, Cell-penetrating peptides-mechanisms of cellular uptake and generation of delivery systems, Pharmaceuticals (Basel), 3, 961, 10.3390/ph3040961 Antohi, 1984, Polycation-cell surface interactions and plasma membrane compartments in mammals. Interference of oligocation with polycationic condensation, Zeitschrift für Naturforschung C, 39, 767, 10.1515/znc-1984-7-816 Zhu, 2007, Synthesis and characterization of PEG modified N-trimethylaminoethylmethacrylate chitosan nanoparticles, Eur. Polym. J., 43, 2244, 10.1016/j.eurpolymj.2007.03.042 Sharma, 2013, Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: biodistribution and transfection, J. Control. Release, 167, 1, 10.1016/j.jconrel.2013.01.016 Amin, 2006, In vitro hemolysis: guidance for the pharmaceutical scientist, J. Pharm. Sci., 95, 1173, 10.1002/jps.20627 Janzer, 1987, Astrocytes induce blood–brain barrier properties in endothelial cells, Nature, 325, 253, 10.1038/325253a0 Arthur, 1987, Astrocyte-mediated induction of tight junctions in brain capillary endothelium: an efficient in vitro model, Dev. Brain Res., 36, 155, 10.1016/0165-3806(87)90075-7 Ramana, 2010, Development of a liposomal nanodelivery system for nevirapine, J. Biomed. Sci., 17, 57, 10.1186/1423-0127-17-57 Lee, 1985, Blood volume in the rat, J. Nucl. Med., 26, 72 Deaglio, 2002, Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum, Blood, 100, 3782, 10.1182/blood-2002-01-0076 Jefferies, 1984, Transferrin receptor on endothelium of brain capillaries, Nature, 312, 162, 10.1038/312162a0 Killion, 1999, Orthotopic models are necessary to predict therapy of transplantable tumors in mice, Cancer Metastasis Rev., 17, 279, 10.1023/A:1006140513233 Jhaveri, 2018, Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma, J. Control. Release, 277, 89, 10.1016/j.jconrel.2018.03.006 Cui, 2013, Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment, Biomaterials, 34, 8511, 10.1016/j.biomaterials.2013.07.075 Gan, 2010, Transferrin-conjugated nanoparticles of Poly(lactide)-d-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier, Biomaterials, 31, 7748, 10.1016/j.biomaterials.2010.06.053 Chen, 2011, Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas, Eur. J. Pharm. Sci., 44, 164, 10.1016/j.ejps.2011.07.007 Salvati, 2013, Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface, Nat. Nanotechnol., 8, 137, 10.1038/nnano.2012.237 Qin, 2014, A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy, Oncol. Lett., 8, 2000, 10.3892/ol.2014.2449 Zhang, 2012, Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy, Mol. Pharm., 9, 1590, 10.1021/mp200600t Wei, 2015, Liposome-based glioma targeted drug delivery enabled by stable peptide ligands, J. Control. Release, 218, 13, 10.1016/j.jconrel.2015.09.059 Lam, 2018, Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles, Nat. Commun., 9, 10.1038/s41467-018-04315-4 Jo, 2015, Radiation-induced autophagy contributes to cell death and induces apoptosis partly in malignant glioma cells, Cancer Res. Treat., 47, 221, 10.4143/crt.2013.159 Casao, 2015, Cleaved PARP-1, an apoptotic marker, can be detected in ram spermatozoa, Reprod. Domest. Anim., 50, 688, 10.1111/rda.12549